Porth Ymchwil

Economic evaluation of infliximab and adalimumab for Crohn's disease.

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

StandardStandard

Economic evaluation of infliximab and adalimumab for Crohn's disease. / Hughes, D.; Hughes, D.A.; Bodger, K. et al.
2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

HarvardHarvard

Hughes, D, Hughes, DA, Bodger, K & Kikuchi, T 2009, 'Economic evaluation of infliximab and adalimumab for Crohn's disease.', Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009., 3/01/02.

APA

Hughes, D., Hughes, D. A., Bodger, K., & Kikuchi, T. (2009). Economic evaluation of infliximab and adalimumab for Crohn's disease.. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

CBE

Hughes D, Hughes DA, Bodger K, Kikuchi T. 2009. Economic evaluation of infliximab and adalimumab for Crohn's disease. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

MLA

Hughes, D. et al. Economic evaluation of infliximab and adalimumab for Crohn's disease.. 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009., 03 Ion 0002, Papur, 2009.

VancouverVancouver

Hughes D, Hughes DA, Bodger K, Kikuchi T. Economic evaluation of infliximab and adalimumab for Crohn's disease.. 2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

Author

Hughes, D. ; Hughes, D.A. ; Bodger, K. et al. / Economic evaluation of infliximab and adalimumab for Crohn's disease. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

RIS

TY - CONF

T1 - Economic evaluation of infliximab and adalimumab for Crohn's disease.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Bodger, K.

AU - Kikuchi, T.

PY - 2009/1/1

Y1 - 2009/1/1

M3 - Paper

T2 - 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009.

Y2 - 3 January 0002

ER -